Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Paul J Sheridan"'
Autor:
Elaine Chow, Alan Bernjak, Jefferson Luiz Brum Marques, Emma J. Robinson, Simon Heller, Paul J. Sheridan, Jenny Freeman, Ian A. Macdonald
Publikováno v:
Diabetologia
Aims/hypothesis We examined the effect of a standardised sympathetic stimulus, incremental adrenaline (epinephrine) infusion on cardiac repolarisation in individuals with type 1 diabetes with normal autonomic function, subclinical autonomic neuropath
Publikováno v:
Heart failure.
Introduction In patients with heart failure with reduced ejection fraction (HFrEF), a raised serum parathyroid hormone (PTH) level is associated with increased morbidity and mortality. Previous studies suggest that PTH levels correlate with peak VO2
Autor:
David R Warriner, Alistair G Brown, Susheel Varma, Paul J Sheridan, Patricia Lawford, David R Hose, Abdallah Al-Mohammad, Yubing Shi
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114153 (2014)
IntroductionThe American Heart Association (AHA)/American College of Cardiology (ACC) guidelines for the classification of heart failure (HF) are descriptive but lack precise and objective measures which would assist in categorising such patients. Ou
Externí odkaz:
https://doaj.org/article/c85998c42ffe40a8a143ca18a0857805
Autor:
Alan Bernjak, Richard Jacques, Scott E. Williams, Michael J. Campbell, Ahmed Iqbal, Simon Heller, Paul J. Sheridan, Peter Novodvorsky, Elaine Chow, Jefferson Luiz Brum Marques, Robert A. Fawdry, L. Sellors
Publikováno v:
Diabetesmetabolism. 47(5)
Aim We examined the effect of spontaneous hyperglycaemia in adults with type 1 diabetes mellitus (T1DM) and without history of cardiovascular disease on heart rate variability (HRV), cardiac repolarisation and incidence of cardiac arrhythmias. Method
Autor:
Simon Heller, Alan Bernjak, Paul J. Sheridan, Jefferson Luiz Brum Marques, Ahmed Iqbal, Emma J. Robinson, Peter Novodvorsky, Richard Jacques, Ian A. Macdonald
Publikováno v:
Diabetic Medicine
Aims Hypoglycaemia causes QT‐interval prolongation and appears pro‐arrhythmogenic. Salbutamol, a β2‐adrenoreceptor agonist also causes QT‐interval prolongation. We hypothesized that the magnitude of electrophysiological changes induced by sa
Autor:
Lianne Sellors, Robert A. Fawdry, Elaine Chow, Richard Jacques, Bhavin Parekh, Ahmed Iqbal, Alan Bernjak, Paul J. Sheridan, Jefferson Luiz Brum Marques, Simon Heller, Peter Novodvorsky, Scott E. Williams
Publikováno v:
Diabetes Care. 40:655-662
OBJECTIVE Hypoglycemia may exert proarrhythmogenic effects on the heart via sympathoadrenal stimulation and hypokalemia. Hypoglycemia-induced cardiac dysrhythmias are linked to the “dead-in-bed syndrome,” a rare but devastating condition. We exam
Publikováno v:
British Journal of Hospital Medicine. 76:330-336
Heart failure is not simply a single organ disease; rather it is a complex multi-system clinical syndrome, with impairment of endocrine, haematological, musculoskeletal, renal, respiratory and vascular systems, which influence morbidity and mortality
Autor:
Alexandra Lubina-Solomon, Elaine Chow, Paul J. Sheridan, Emma Walkinshaw, Alan Bernjak, Ian A. Macdonald, Simon Heller, Jenny Freeman
Publikováno v:
Diabetes
Hypoglycemia is associated with increased cardiovascular mortality in trials of intensive therapy in type 2 diabetes mellitus (T2DM). We previously observed an increase in arrhythmias during spontaneous prolonged hypoglycemia in patients with T2DM. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be95646a0200f984d391ab22e91464
https://eprints.whiterose.ac.uk/111566/3/DiabetesHRVpaperrevised211216_repository.pdf
https://eprints.whiterose.ac.uk/111566/3/DiabetesHRVpaperrevised211216_repository.pdf
Publikováno v:
Postgraduate Medical Journal. 90:520-528
Warfarin, a vitamin K antagonist, is the most widely used oral anticoagulant in the world. It is cheap and effective, but its use is limited in many patients by unpredictable levels of anticoagulation, which increases the risk of thromboembolic or ha
Autor:
Paul J. Sheridan, Alan Bernjak, Scott E. Williams, Robert A. Fawdry, Jenny Freeman, Elaine Chow, Simon Heller, Steve Hibbert
Publikováno v:
Diabetes
Recent trials of intensive glycemic control suggest a possible link between hypoglycemia and excess cardiovascular mortality in patients with type 2 diabetes. Hypoglycemia might cause arrhythmias through effects on cardiac repolarization and changes